Raymond James Financial Services Advisors, Inc. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$493,240
-19.9%
31,080
-4.8%
0.00%0.0%
Q2 2023$616,068
+192.0%
32,648
-40.6%
0.00%
Q1 2023$210,966
-15.1%
54,939
+9.6%
0.00%
Q4 2022$248,531
+148.5%
50,107
+140.4%
0.00%
Q3 2022$100,000
+11.1%
20,846
+4.3%
0.00%
Q2 2022$90,000
-28.6%
19,981
-24.4%
0.00%
Q1 2022$126,000
-22.2%
26,421
+20.8%
0.00%
Q4 2021$162,000
+27.6%
21,873
-2.2%
0.00%
Q3 2021$127,000
-18.1%
22,369
-5.0%
0.00%
Q2 2021$155,000
-28.9%
23,551
-12.6%
0.00%
Q1 2021$218,000
+16.0%
26,950
-7.8%
0.00%
Q4 2020$188,000
+193.8%
29,219
+63.5%
0.00%
Q3 2020$64,000
-20.0%
17,868
+2.8%
0.00%
Q2 2020$80,000
+27.0%
17,376
-5.3%
0.00%
Q1 2020$63,000
-28.4%
18,344
+7.0%
0.00%
Q4 2019$88,000
+104.7%
17,149
-3.8%
0.00%
Q3 2019$43,000
+19.4%
17,835
+6.9%
0.00%
Q2 2019$36,000
-16.3%
16,684
+5.7%
0.00%
Q1 2019$43,000
-42.7%
15,790
+1.4%
0.00%
Q4 2018$75,000
-54.0%
15,569
-9.4%
0.00%
-100.0%
Q3 2018$163,000
+5.2%
17,181
+8.0%
0.00%0.0%
Q2 2018$155,000
-59.1%
15,913
-55.9%
0.00%
-50.0%
Q1 2018$379,000
+392.2%
36,066
+198.5%
0.00%
Q4 2017$77,000
-55.5%
12,084
-46.6%
0.00%
-100.0%
Q3 2017$173,000
+37.3%
22,648
+27.9%
0.00%0.0%
Q2 2017$126,00017,7060.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders